[1]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.1071-1074
[1]Patent:WO2017/93727,2017,A1.Locationinpatent:Paragraph00177-00180
1999-00-4
2928-14-5
63131-29-3
620-79-1
7116-38-3
24106-86-3
878627-21-5 | N-TRIDECANOYL-L-HOMSERINE LACTONE | AA00GT8P | MFCD11976907
886498-56-2 | 2-Methoxy-4-fluorobenzyl cyanide | AA00GTDJ | MFCD06660192
915922-34-8 | 3-Allyl-4-ethoxybenzaldehyde | AA00GTL8 | MFCD08691768
915922-40-6 | (3-Bromo-4-propoxyphenyl)methanol | AA00GTOT | MFCD08691776
897365-76-3 | 6-Chloro-3-(3-chloro-2-fluorobenzylidene)indolin-2-one | AA00GTWG | MFCD16038628
917910-45-3 | 2-{3-[3-(5-hydroxypyridin-2-yl)-1,2,4-oxadiazol-5-yl]-2,2-dimethylpropanamido}cyclohex-1-ene-1-carboxylic acid | AA00GU1M | MFCD20528236
900185-02-6 | PIK-294 | AA00GU6M | MFCD17019338
861521-66-6 | N-(Aminocarbonyl)-2-(2-nitrophenoxy)acetamide | AA00GUAD | MFCD08691360
914347-91-4 | Ethyl 3-fluoro-4-nitrobenzoate | AA00GUDR | MFCD07782042
888711-49-7 | Potassium trifluoro[(thien-2-yl)methyl]borate | AA00GUM7 | MFCD11617926